CHLORAPREP WITH TINT (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
CHLORAPREP WITH TINT is a topical antiseptic sponge combining chlorhexidine gluconate and isopropyl alcohol, indicated for bacterial skin preparation prior to surgical and medical procedures. It provides rapid antimicrobial activity and includes a visible tint for application verification. The product is designed for pre-operative site antisepsis in healthcare settings.
With LOE approaching in 2027, the brand team faces significant portfolio transition pressure; positions in this franchise are consolidating toward support and compliance roles rather than growth-focused expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLORAPREP WITH TINT at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Patent cliff in less than a year — expect lifecycle management and generic defense hiring
CHLORAPREP WITH TINT offers limited career advancement given its LOE-approaching status and zero linked job postings; professionals on this franchise face accelerated obsolescence risk and should position themselves for transition to pipeline products or adjacent BD portfolios. Remaining roles focus on compliance, regulatory defense, and managed decline rather than growth or innovation.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo